Found: 36
Select item for more details and to access through your institution.
Anti-ischaemic activity of an antioxidant aldose reductase inhibitor on diabetic and non-diabetic rat hearts.
- Published in:
- Journal of Pharmacy & Pharmacology, 2010, v. 62, n. 1, p. 107, doi. 10.1211/jpp.62.01.0012
- By:
- Publication type:
- Article
New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 10, p. 2369, doi. 10.3390/pharmaceutics15102369
- By:
- Publication type:
- Article
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6689, doi. 10.3390/ijms24076689
- By:
- Publication type:
- Article
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2398, doi. 10.3390/ijms24032398
- By:
- Publication type:
- Article
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6325, doi. 10.3390/ijms22126325
- By:
- Publication type:
- Article
CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 2, p. E288, doi. 10.1210/jc.2010-1905
- By:
- Publication type:
- Article
Synthesis and in vitro antiproliferative activity of new substituted benzo[3′,2′:5,6]thiopyrano[4,3- d]pyrimidines.
- Published in:
- Journal of Heterocyclic Chemistry, 2008, v. 45, n. 3, p. 745, doi. 10.1002/jhet.5570450318
- By:
- Publication type:
- Article
Synthesis of New Heterocyclic Ring Systems via [1,3,5]Triazino[1,2- a]benzimidazole Derivatives.
- Published in:
- Journal of Heterocyclic Chemistry, 2005, v. 42, n. 7, p. 1417, doi. 10.1002/jhet.5570420725
- By:
- Publication type:
- Article
Synthesis of novel pyrido[3′,2′:5,6]thiopyrano[3,2- b]indol-5(6 H)-ones and 6 H-pyrido[3′,2′:5,6]thiopyrano[4,3- b]quinolines, two new heterocyclic ring systems.
- Published in:
- Journal of Heterocyclic Chemistry, 2002, v. 39, n. 5, p. 1001, doi. 10.1002/jhet.5570390522
- By:
- Publication type:
- Article
Synthesis of novel 5 H, 11 H-pyrido[2′,3′:2,3]thiopyrano[4,3- b]-indoles by fischer-indole cyclization.
- Published in:
- Journal of Heterocyclic Chemistry, 2000, v. 37, n. 2, p. 379, doi. 10.1002/jhet.5570370224
- By:
- Publication type:
- Article
Synthesis of a novel purine-containing heterocyclic ring system: 8,10-Dimethylindolo[2′,3′:5,6][1,2,4]triazino[4,3- f]purine-9,11(8 H, 10 H, 13 H)-dione.
- Published in:
- Journal of Heterocyclic Chemistry, 2000, v. 37, n. 2, p. 373, doi. 10.1002/jhet.5570370223
- By:
- Publication type:
- Article
Synthesis of purinobenzodiazepine and purinobenzotriazocine derivatives, two new heterocyclic ring systems.
- Published in:
- Journal of Heterocyclic Chemistry, 1999, v. 36, n. 3, p. 639, doi. 10.1002/jhet.5570360311
- By:
- Publication type:
- Article
Synthesis of novel 1-aryl[1]benzoxepino[5,4- c]pyrazole and [1]benzoxepino[5,4- d]pyrimidine derivatives.
- Published in:
- Journal of Heterocyclic Chemistry, 1993, v. 30, n. 6, p. 1653, doi. 10.1002/jhet.5570300632
- By:
- Publication type:
- Article
A New Approach to Control the Enigmatic Activity of Aldose Reductase.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074076
- By:
- Publication type:
- Article
Nature-Inspired O -Benzyl Oxime-Based Derivatives as New Dual-Acting Agents Targeting Aldose Reductase and Oxidative Stress.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 3, p. 448, doi. 10.3390/biom12030448
- By:
- Publication type:
- Article
A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2397, doi. 10.3390/cancers16132397
- By:
- Publication type:
- Article
A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 356, doi. 10.3390/cancers13020356
- By:
- Publication type:
- Article
Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug.
- Published in:
- International Journal of Nanomedicine, 2016, v. 11, p. 69, doi. 10.2147/IJN.S92031
- By:
- Publication type:
- Article
Complexing the Marine Sesquiterpene Euplotin C by Means of Cyclodextrin-Based Nanosponges: A Preliminary Investigation.
- Published in:
- Marine Drugs, 2022, v. 20, n. 11, p. 682, doi. 10.3390/md20110682
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of 2′-Oxo-2,3-dihydro-3′ H- spiro[chromene-4,5′-[1,3]oxazolidin]-3′yl]acetic Acid Derivatives as Aldose Reductase Inhibitors.
- Published in:
- Archiv der Pharmazie, 2011, v. 344, n. 6, p. 372, doi. 10.1002/ardp.201000302
- By:
- Publication type:
- Article
Synthesis and Benzodiazepine Receptor Affinity of Derivatives of the New Tricyclic Heteroaromatic System Pyrido[3′,2′:5,6]thiopyrano[4,3-c]pyridazin-3(2H,5H)-one.
- Published in:
- Archiv der Pharmazie, 2005, v. 338, n. 2/3, p. 126, doi. 10.1002/ardp.200400948
- By:
- Publication type:
- Article
Aurones: A Golden Resource for Active Compounds.
- Published in:
- Molecules, 2022, v. 27, n. 1, p. 2, doi. 10.3390/molecules27010002
- By:
- Publication type:
- Article
Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46287-5
- By:
- Publication type:
- Article
The Use of the Coenzyme Q 10 as a Food Supplement in the Management of Fibromyalgia: A Critical Review.
- Published in:
- Antioxidants, 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antiox11101969
- By:
- Publication type:
- Article
Improving the Bioaccessibility and Bioavailability of Carotenoids by Means of Nanostructured Delivery Systems: A Comprehensive Review.
- Published in:
- Antioxidants, 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antiox11101931
- By:
- Publication type:
- Article
5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease.
- Published in:
- Biomedicines, 2021, v. 9, n. 5, p. 578, doi. 10.3390/biomedicines9050578
- By:
- Publication type:
- Article
Anti-NLRP3 Inflammasome Natural Compounds: An Update.
- Published in:
- Biomedicines, 2021, v. 9, n. 2, p. 136, doi. 10.3390/biomedicines9020136
- By:
- Publication type:
- Article
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target.
- Published in:
- Biomedicines, 2020, v. 8, n. 12, p. 569, doi. 10.3390/biomedicines8120569
- By:
- Publication type:
- Article
How Reliable Are Current Docking Approaches for Structure-Based Drug Design? Lessons from Aldose Reductase.
- Published in:
- Angewandte Chemie International Edition, 2007, v. 46, n. 19, p. 3575, doi. 10.1002/anie.200603625
- By:
- Publication type:
- Article
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis.
- Published in:
- ChemMedChem, 2016, v. 11, n. 16, p. 1804, doi. 10.1002/cmdc.201600086
- By:
- Publication type:
- Article
Derivatives of Benzimidazol-2-ylquinoline and Benzimidazol-2-ylisoquinoline as Selective A<sub>1</sub> Adenosine Receptor Antagonists with Stimulant Activity on Human Colon Motility.
- Published in:
- ChemMedChem, 2011, v. 6, n. 10, p. 1909, doi. 10.1002/cmdc.201100284
- By:
- Publication type:
- Article
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6734, doi. 10.3390/ijms25126734
- By:
- Publication type:
- Article
A<sub>1</sub> adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3- a]benzimidazol-4-(10 H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2- a][1,3,5]triazin-4-yl)amines (ITAs): Different recognition of bovine and human binding sites
- Published in:
- Drug Development Research, 2004, v. 63, n. 1, p. 1, doi. 10.1002/ddr.10366
- By:
- Publication type:
- Article
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.
- Published in:
- Oncology Reports, 2018, v. 39, n. 5, p. 2306, doi. 10.3892/or.2018.6305
- By:
- Publication type:
- Article
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
- Published in:
- Oncology Reports, 2018, v. 39, n. 5, p. 2225, doi. 10.3892/or.2018.6306
- By:
- Publication type:
- Article